2022 Top News from Drug Topics

Researchers explore trends from 2014 to 2022 among pediatric invasive pneumococcal diseases since introduction of the 13-valent pneumococcal conjugate vaccine.

LucyRx is empowering pharmacists and impacting patients’ health outcomes with its business model unlike other market-leading pharmacy benefit managers.

Investigators find that orforglipron lowered A1c by an average of 1.3% to 1.6% from a baseline of 8% across 3 different dosages.

Throughout her research, Jenny Markell, BA, has uncovered some alarming trends within prescription drug advertising in the US.

Crystal Hodge discusses being transparent about adverse effects of the MMR vaccine and educating patients about measles.

The approval is based on 2 phase 3 studies demonstrating reductions in itch severity and urticaria activity as a composite of itch and hives at 24 weeks.